Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | Opicapone in PD with motor fluctuations: post-hoc analysis of BIPARK-I and II

Georg Ebersbach • 27 May 2020
EAN 2020
Movement Disorders Parkinson's Disease Levodopa Opicapone
BIPARK-I BIPARK-II

Georg Ebersbach, MD, Movement Disorders Clinic, Beelitz‐Heilstätten, Germany, discusses the efficacy and safety of opicapone in Parkinson’s disease patients according to the duration of motor fluctuations. In particular, Dr Ebersbach outlines the post-hoc analysis of the BIPARK-I and BIPARK-II trials. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Georg Ebersbach

Future treatment directions for Parkinson's disease
2:40
Future treatment directions for Parkinson's disease
Georg Ebersbach • 27 May 2020
Parkinson's disease: physiotherapy, speech and occupational therapy
2:07
Parkinson's disease: physiotherapy, speech and occupational therapy
Georg Ebersbach • 27 May 2020
OPTIPARK trial: opicapone in clinical practice
3:59
OPTIPARK trial: opicapone in clinical practice
Georg Ebersbach • 27 May 2020

Related Videos

Current treatment and unmet needs in neurologic Wilson's disease
3:15
Current treatment and unmet needs in neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Emerging therapies for neurologic Wilson's disease
2:42
Emerging therapies for neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Findings from the Phase III FoCus trial: tiomolibdate choline for neurologic Wilson's disease
3:18
Findings from the Phase III FoCus trial: tiomolibdate choline for neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Indicators of advanced-stage Parkinson’s disease
2:30
Indicators of advanced-stage Parkinson’s disease
K. Ray Chaudhuri • 30 Jun 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals